Global Biciruizumab Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Biciruizumab market size was valued at US$ 2592 million in 2025 and is forecast to a readjusted size of US$ 8879 million by 2032 with a CAGR of 14.6% during review period.
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab’s use in other cancer types continues to expand, it is expected that the drug’s indications will continue to grow, further driving market growth.
This report is a detailed and comprehensive analysis for global Biciruizumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biciruizumab market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biciruizumab market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biciruizumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biciruizumab, with price, sales quantity, revenue, and global market share of Biciruizumab from 2021 to 2026.
Chapter 3, the Biciruizumab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biciruizumab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biciruizumab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biciruizumab.
Chapter 14 and 15, to describe Biciruizumab sales channel, distributors, customers, research findings and conclusion.
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab’s use in other cancer types continues to expand, it is expected that the drug’s indications will continue to grow, further driving market growth.
This report is a detailed and comprehensive analysis for global Biciruizumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biciruizumab market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Biciruizumab market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Biciruizumab
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biciruizumab market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 100 mg/4 mL
- 320 mg/2 mL
- Bimekizumab In Combination With Methotrexate
- Bimekizumab Combined With Topical Corticosteroids
- Hospital
- Retail
- Online
- Intravenous Injection
- Subcutaneous Injection
- Psoriasis
- Ankylosing Spondylitis
- Hidradenitis Suppurativa
- Others
- Roche
- Chugai Pharmaceutical
- Amgen
- Pfizer
- Qilu Pharmaceutical
- Innovent Biologics
- Jiangsu Hengrui Medicine
- Shandong Boan Biotechnology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biciruizumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biciruizumab, with price, sales quantity, revenue, and global market share of Biciruizumab from 2021 to 2026.
Chapter 3, the Biciruizumab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biciruizumab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biciruizumab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biciruizumab.
Chapter 14 and 15, to describe Biciruizumab sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biciruizumab Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 100 mg/4 mL
1.3.3 320 mg/2 mL
1.4 Market Analysis by Specification
1.4.1 Overview: Global Biciruizumab Consumption Value by Specification: 2021 Versus 2025 Versus 2032
1.4.2 Bimekizumab In Combination With Methotrexate
1.4.3 Bimekizumab Combined With Topical Corticosteroids
1.5 Market Analysis by Sales Channels
1.5.1 Overview: Global Biciruizumab Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Dosage Form
1.6.1 Overview: Global Biciruizumab Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
1.6.2 Intravenous Injection
1.6.3 Subcutaneous Injection
1.7 Market Analysis by Application
1.7.1 Overview: Global Biciruizumab Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Psoriasis
1.7.3 Ankylosing Spondylitis
1.7.4 Hidradenitis Suppurativa
1.7.5 Others
1.8 Global Biciruizumab Market Size & Forecast
1.8.1 Global Biciruizumab Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Biciruizumab Sales Quantity (2021-2032)
1.8.3 Global Biciruizumab Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biciruizumab Product and Services
2.1.4 Roche Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Chugai Pharmaceutical
2.2.1 Chugai Pharmaceutical Details
2.2.2 Chugai Pharmaceutical Major Business
2.2.3 Chugai Pharmaceutical Biciruizumab Product and Services
2.2.4 Chugai Pharmaceutical Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Chugai Pharmaceutical Recent Developments/Updates
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Biciruizumab Product and Services
2.3.4 Amgen Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Amgen Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Biciruizumab Product and Services
2.4.4 Pfizer Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 Qilu Pharmaceutical
2.5.1 Qilu Pharmaceutical Details
2.5.2 Qilu Pharmaceutical Major Business
2.5.3 Qilu Pharmaceutical Biciruizumab Product and Services
2.5.4 Qilu Pharmaceutical Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Qilu Pharmaceutical Recent Developments/Updates
2.6 Innovent Biologics
2.6.1 Innovent Biologics Details
2.6.2 Innovent Biologics Major Business
2.6.3 Innovent Biologics Biciruizumab Product and Services
2.6.4 Innovent Biologics Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Innovent Biologics Recent Developments/Updates
2.7 Jiangsu Hengrui Medicine
2.7.1 Jiangsu Hengrui Medicine Details
2.7.2 Jiangsu Hengrui Medicine Major Business
2.7.3 Jiangsu Hengrui Medicine Biciruizumab Product and Services
2.7.4 Jiangsu Hengrui Medicine Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.8 Shandong Boan Biotechnology
2.8.1 Shandong Boan Biotechnology Details
2.8.2 Shandong Boan Biotechnology Major Business
2.8.3 Shandong Boan Biotechnology Biciruizumab Product and Services
2.8.4 Shandong Boan Biotechnology Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Shandong Boan Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BICIRUIZUMAB BY MANUFACTURER
3.1 Global Biciruizumab Sales Quantity by Manufacturer (2021-2026)
3.2 Global Biciruizumab Revenue by Manufacturer (2021-2026)
3.3 Global Biciruizumab Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Biciruizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Biciruizumab Manufacturer Market Share in 2025
3.4.3 Top 6 Biciruizumab Manufacturer Market Share in 2025
3.5 Biciruizumab Market: Overall Company Footprint Analysis
3.5.1 Biciruizumab Market: Region Footprint
3.5.2 Biciruizumab Market: Company Product Type Footprint
3.5.3 Biciruizumab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biciruizumab Market Size by Region
4.1.1 Global Biciruizumab Sales Quantity by Region (2021-2032)
4.1.2 Global Biciruizumab Consumption Value by Region (2021-2032)
4.1.3 Global Biciruizumab Average Price by Region (2021-2032)
4.2 North America Biciruizumab Consumption Value (2021-2032)
4.3 Europe Biciruizumab Consumption Value (2021-2032)
4.4 Asia-Pacific Biciruizumab Consumption Value (2021-2032)
4.5 South America Biciruizumab Consumption Value (2021-2032)
4.6 Middle East & Africa Biciruizumab Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Biciruizumab Sales Quantity by Type (2021-2032)
5.2 Global Biciruizumab Consumption Value by Type (2021-2032)
5.3 Global Biciruizumab Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biciruizumab Sales Quantity by Application (2021-2032)
6.2 Global Biciruizumab Consumption Value by Application (2021-2032)
6.3 Global Biciruizumab Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Biciruizumab Sales Quantity by Type (2021-2032)
7.2 North America Biciruizumab Sales Quantity by Application (2021-2032)
7.3 North America Biciruizumab Market Size by Country
7.3.1 North America Biciruizumab Sales Quantity by Country (2021-2032)
7.3.2 North America Biciruizumab Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Biciruizumab Sales Quantity by Type (2021-2032)
8.2 Europe Biciruizumab Sales Quantity by Application (2021-2032)
8.3 Europe Biciruizumab Market Size by Country
8.3.1 Europe Biciruizumab Sales Quantity by Country (2021-2032)
8.3.2 Europe Biciruizumab Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biciruizumab Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Biciruizumab Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Biciruizumab Market Size by Region
9.3.1 Asia-Pacific Biciruizumab Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Biciruizumab Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Biciruizumab Sales Quantity by Type (2021-2032)
10.2 South America Biciruizumab Sales Quantity by Application (2021-2032)
10.3 South America Biciruizumab Market Size by Country
10.3.1 South America Biciruizumab Sales Quantity by Country (2021-2032)
10.3.2 South America Biciruizumab Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biciruizumab Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Biciruizumab Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Biciruizumab Market Size by Country
11.3.1 Middle East & Africa Biciruizumab Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Biciruizumab Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Biciruizumab Market Drivers
12.2 Biciruizumab Market Restraints
12.3 Biciruizumab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biciruizumab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biciruizumab
13.3 Biciruizumab Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biciruizumab Typical Distributors
14.3 Biciruizumab Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biciruizumab Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 100 mg/4 mL
1.3.3 320 mg/2 mL
1.4 Market Analysis by Specification
1.4.1 Overview: Global Biciruizumab Consumption Value by Specification: 2021 Versus 2025 Versus 2032
1.4.2 Bimekizumab In Combination With Methotrexate
1.4.3 Bimekizumab Combined With Topical Corticosteroids
1.5 Market Analysis by Sales Channels
1.5.1 Overview: Global Biciruizumab Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Dosage Form
1.6.1 Overview: Global Biciruizumab Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
1.6.2 Intravenous Injection
1.6.3 Subcutaneous Injection
1.7 Market Analysis by Application
1.7.1 Overview: Global Biciruizumab Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Psoriasis
1.7.3 Ankylosing Spondylitis
1.7.4 Hidradenitis Suppurativa
1.7.5 Others
1.8 Global Biciruizumab Market Size & Forecast
1.8.1 Global Biciruizumab Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Biciruizumab Sales Quantity (2021-2032)
1.8.3 Global Biciruizumab Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biciruizumab Product and Services
2.1.4 Roche Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Chugai Pharmaceutical
2.2.1 Chugai Pharmaceutical Details
2.2.2 Chugai Pharmaceutical Major Business
2.2.3 Chugai Pharmaceutical Biciruizumab Product and Services
2.2.4 Chugai Pharmaceutical Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Chugai Pharmaceutical Recent Developments/Updates
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Biciruizumab Product and Services
2.3.4 Amgen Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Amgen Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Biciruizumab Product and Services
2.4.4 Pfizer Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 Qilu Pharmaceutical
2.5.1 Qilu Pharmaceutical Details
2.5.2 Qilu Pharmaceutical Major Business
2.5.3 Qilu Pharmaceutical Biciruizumab Product and Services
2.5.4 Qilu Pharmaceutical Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Qilu Pharmaceutical Recent Developments/Updates
2.6 Innovent Biologics
2.6.1 Innovent Biologics Details
2.6.2 Innovent Biologics Major Business
2.6.3 Innovent Biologics Biciruizumab Product and Services
2.6.4 Innovent Biologics Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Innovent Biologics Recent Developments/Updates
2.7 Jiangsu Hengrui Medicine
2.7.1 Jiangsu Hengrui Medicine Details
2.7.2 Jiangsu Hengrui Medicine Major Business
2.7.3 Jiangsu Hengrui Medicine Biciruizumab Product and Services
2.7.4 Jiangsu Hengrui Medicine Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.8 Shandong Boan Biotechnology
2.8.1 Shandong Boan Biotechnology Details
2.8.2 Shandong Boan Biotechnology Major Business
2.8.3 Shandong Boan Biotechnology Biciruizumab Product and Services
2.8.4 Shandong Boan Biotechnology Biciruizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Shandong Boan Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BICIRUIZUMAB BY MANUFACTURER
3.1 Global Biciruizumab Sales Quantity by Manufacturer (2021-2026)
3.2 Global Biciruizumab Revenue by Manufacturer (2021-2026)
3.3 Global Biciruizumab Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Biciruizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Biciruizumab Manufacturer Market Share in 2025
3.4.3 Top 6 Biciruizumab Manufacturer Market Share in 2025
3.5 Biciruizumab Market: Overall Company Footprint Analysis
3.5.1 Biciruizumab Market: Region Footprint
3.5.2 Biciruizumab Market: Company Product Type Footprint
3.5.3 Biciruizumab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biciruizumab Market Size by Region
4.1.1 Global Biciruizumab Sales Quantity by Region (2021-2032)
4.1.2 Global Biciruizumab Consumption Value by Region (2021-2032)
4.1.3 Global Biciruizumab Average Price by Region (2021-2032)
4.2 North America Biciruizumab Consumption Value (2021-2032)
4.3 Europe Biciruizumab Consumption Value (2021-2032)
4.4 Asia-Pacific Biciruizumab Consumption Value (2021-2032)
4.5 South America Biciruizumab Consumption Value (2021-2032)
4.6 Middle East & Africa Biciruizumab Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Biciruizumab Sales Quantity by Type (2021-2032)
5.2 Global Biciruizumab Consumption Value by Type (2021-2032)
5.3 Global Biciruizumab Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biciruizumab Sales Quantity by Application (2021-2032)
6.2 Global Biciruizumab Consumption Value by Application (2021-2032)
6.3 Global Biciruizumab Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Biciruizumab Sales Quantity by Type (2021-2032)
7.2 North America Biciruizumab Sales Quantity by Application (2021-2032)
7.3 North America Biciruizumab Market Size by Country
7.3.1 North America Biciruizumab Sales Quantity by Country (2021-2032)
7.3.2 North America Biciruizumab Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Biciruizumab Sales Quantity by Type (2021-2032)
8.2 Europe Biciruizumab Sales Quantity by Application (2021-2032)
8.3 Europe Biciruizumab Market Size by Country
8.3.1 Europe Biciruizumab Sales Quantity by Country (2021-2032)
8.3.2 Europe Biciruizumab Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biciruizumab Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Biciruizumab Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Biciruizumab Market Size by Region
9.3.1 Asia-Pacific Biciruizumab Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Biciruizumab Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Biciruizumab Sales Quantity by Type (2021-2032)
10.2 South America Biciruizumab Sales Quantity by Application (2021-2032)
10.3 South America Biciruizumab Market Size by Country
10.3.1 South America Biciruizumab Sales Quantity by Country (2021-2032)
10.3.2 South America Biciruizumab Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biciruizumab Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Biciruizumab Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Biciruizumab Market Size by Country
11.3.1 Middle East & Africa Biciruizumab Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Biciruizumab Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Biciruizumab Market Drivers
12.2 Biciruizumab Market Restraints
12.3 Biciruizumab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biciruizumab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biciruizumab
13.3 Biciruizumab Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biciruizumab Typical Distributors
14.3 Biciruizumab Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biciruizumab Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biciruizumab Consumption Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biciruizumab Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biciruizumab Consumption Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biciruizumab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Roche Basic Information, Manufacturing Base and Competitors
Table 7. Roche Major Business
Table 8. Roche Biciruizumab Product and Services
Table 9. Roche Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Roche Recent Developments/Updates
Table 11. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Chugai Pharmaceutical Major Business
Table 13. Chugai Pharmaceutical Biciruizumab Product and Services
Table 14. Chugai Pharmaceutical Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Chugai Pharmaceutical Recent Developments/Updates
Table 16. Amgen Basic Information, Manufacturing Base and Competitors
Table 17. Amgen Major Business
Table 18. Amgen Biciruizumab Product and Services
Table 19. Amgen Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Amgen Recent Developments/Updates
Table 21. Pfizer Basic Information, Manufacturing Base and Competitors
Table 22. Pfizer Major Business
Table 23. Pfizer Biciruizumab Product and Services
Table 24. Pfizer Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Pfizer Recent Developments/Updates
Table 26. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 27. Qilu Pharmaceutical Major Business
Table 28. Qilu Pharmaceutical Biciruizumab Product and Services
Table 29. Qilu Pharmaceutical Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Qilu Pharmaceutical Recent Developments/Updates
Table 31. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Innovent Biologics Major Business
Table 33. Innovent Biologics Biciruizumab Product and Services
Table 34. Innovent Biologics Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Innovent Biologics Recent Developments/Updates
Table 36. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 37. Jiangsu Hengrui Medicine Major Business
Table 38. Jiangsu Hengrui Medicine Biciruizumab Product and Services
Table 39. Jiangsu Hengrui Medicine Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 41. Shandong Boan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 42. Shandong Boan Biotechnology Major Business
Table 43. Shandong Boan Biotechnology Biciruizumab Product and Services
Table 44. Shandong Boan Biotechnology Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Shandong Boan Biotechnology Recent Developments/Updates
Table 46. Global Biciruizumab Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 47. Global Biciruizumab Revenue by Manufacturer (2021-2026) & (USD Million)
Table 48. Global Biciruizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 49. Market Position of Manufacturers in Biciruizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 50. Head Office and Biciruizumab Production Site of Key Manufacturer
Table 51. Biciruizumab Market: Company Product Type Footprint
Table 52. Biciruizumab Market: Company Product Application Footprint
Table 53. Biciruizumab New Market Entrants and Barriers to Market Entry
Table 54. Biciruizumab Mergers, Acquisition, Agreements, and Collaborations
Table 55. Global Biciruizumab Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 56. Global Biciruizumab Sales Quantity by Region (2021-2026) & (Units)
Table 57. Global Biciruizumab Sales Quantity by Region (2027-2032) & (Units)
Table 58. Global Biciruizumab Consumption Value by Region (2021-2026) & (USD Million)
Table 59. Global Biciruizumab Consumption Value by Region (2027-2032) & (USD Million)
Table 60. Global Biciruizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 61. Global Biciruizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 62. Global Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 63. Global Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 64. Global Biciruizumab Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Global Biciruizumab Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Global Biciruizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 67. Global Biciruizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 68. Global Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 69. Global Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 70. Global Biciruizumab Consumption Value by Application (2021-2026) & (USD Million)
Table 71. Global Biciruizumab Consumption Value by Application (2027-2032) & (USD Million)
Table 72. Global Biciruizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 73. Global Biciruizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 74. North America Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 75. North America Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 76. North America Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 77. North America Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 78. North America Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 79. North America Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 80. North America Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 81. North America Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Europe Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 83. Europe Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 84. Europe Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 85. Europe Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 86. Europe Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 87. Europe Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 88. Europe Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 91. Asia-Pacific Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 92. Asia-Pacific Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 93. Asia-Pacific Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 94. Asia-Pacific Biciruizumab Sales Quantity by Region (2021-2026) & (Units)
Table 95. Asia-Pacific Biciruizumab Sales Quantity by Region (2027-2032) & (Units)
Table 96. Asia-Pacific Biciruizumab Consumption Value by Region (2021-2026) & (USD Million)
Table 97. Asia-Pacific Biciruizumab Consumption Value by Region (2027-2032) & (USD Million)
Table 98. South America Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 99. South America Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 100. South America Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 101. South America Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 102. South America Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 103. South America Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 104. South America Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 105. South America Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Middle East & Africa Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 107. Middle East & Africa Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 108. Middle East & Africa Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 109. Middle East & Africa Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 110. Middle East & Africa Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 111. Middle East & Africa Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 112. Middle East & Africa Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Biciruizumab Raw Material
Table 115. Key Manufacturers of Biciruizumab Raw Materials
Table 116. Biciruizumab Typical Distributors
Table 117. Biciruizumab Typical Customers
Table 1. Global Biciruizumab Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biciruizumab Consumption Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biciruizumab Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biciruizumab Consumption Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biciruizumab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Roche Basic Information, Manufacturing Base and Competitors
Table 7. Roche Major Business
Table 8. Roche Biciruizumab Product and Services
Table 9. Roche Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Roche Recent Developments/Updates
Table 11. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Chugai Pharmaceutical Major Business
Table 13. Chugai Pharmaceutical Biciruizumab Product and Services
Table 14. Chugai Pharmaceutical Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Chugai Pharmaceutical Recent Developments/Updates
Table 16. Amgen Basic Information, Manufacturing Base and Competitors
Table 17. Amgen Major Business
Table 18. Amgen Biciruizumab Product and Services
Table 19. Amgen Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Amgen Recent Developments/Updates
Table 21. Pfizer Basic Information, Manufacturing Base and Competitors
Table 22. Pfizer Major Business
Table 23. Pfizer Biciruizumab Product and Services
Table 24. Pfizer Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Pfizer Recent Developments/Updates
Table 26. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 27. Qilu Pharmaceutical Major Business
Table 28. Qilu Pharmaceutical Biciruizumab Product and Services
Table 29. Qilu Pharmaceutical Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Qilu Pharmaceutical Recent Developments/Updates
Table 31. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Innovent Biologics Major Business
Table 33. Innovent Biologics Biciruizumab Product and Services
Table 34. Innovent Biologics Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Innovent Biologics Recent Developments/Updates
Table 36. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 37. Jiangsu Hengrui Medicine Major Business
Table 38. Jiangsu Hengrui Medicine Biciruizumab Product and Services
Table 39. Jiangsu Hengrui Medicine Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 41. Shandong Boan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 42. Shandong Boan Biotechnology Major Business
Table 43. Shandong Boan Biotechnology Biciruizumab Product and Services
Table 44. Shandong Boan Biotechnology Biciruizumab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Shandong Boan Biotechnology Recent Developments/Updates
Table 46. Global Biciruizumab Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 47. Global Biciruizumab Revenue by Manufacturer (2021-2026) & (USD Million)
Table 48. Global Biciruizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 49. Market Position of Manufacturers in Biciruizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 50. Head Office and Biciruizumab Production Site of Key Manufacturer
Table 51. Biciruizumab Market: Company Product Type Footprint
Table 52. Biciruizumab Market: Company Product Application Footprint
Table 53. Biciruizumab New Market Entrants and Barriers to Market Entry
Table 54. Biciruizumab Mergers, Acquisition, Agreements, and Collaborations
Table 55. Global Biciruizumab Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 56. Global Biciruizumab Sales Quantity by Region (2021-2026) & (Units)
Table 57. Global Biciruizumab Sales Quantity by Region (2027-2032) & (Units)
Table 58. Global Biciruizumab Consumption Value by Region (2021-2026) & (USD Million)
Table 59. Global Biciruizumab Consumption Value by Region (2027-2032) & (USD Million)
Table 60. Global Biciruizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 61. Global Biciruizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 62. Global Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 63. Global Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 64. Global Biciruizumab Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Global Biciruizumab Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Global Biciruizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 67. Global Biciruizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 68. Global Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 69. Global Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 70. Global Biciruizumab Consumption Value by Application (2021-2026) & (USD Million)
Table 71. Global Biciruizumab Consumption Value by Application (2027-2032) & (USD Million)
Table 72. Global Biciruizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 73. Global Biciruizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 74. North America Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 75. North America Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 76. North America Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 77. North America Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 78. North America Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 79. North America Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 80. North America Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 81. North America Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Europe Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 83. Europe Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 84. Europe Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 85. Europe Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 86. Europe Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 87. Europe Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 88. Europe Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 89. Europe Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Asia-Pacific Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 91. Asia-Pacific Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 92. Asia-Pacific Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 93. Asia-Pacific Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 94. Asia-Pacific Biciruizumab Sales Quantity by Region (2021-2026) & (Units)
Table 95. Asia-Pacific Biciruizumab Sales Quantity by Region (2027-2032) & (Units)
Table 96. Asia-Pacific Biciruizumab Consumption Value by Region (2021-2026) & (USD Million)
Table 97. Asia-Pacific Biciruizumab Consumption Value by Region (2027-2032) & (USD Million)
Table 98. South America Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 99. South America Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 100. South America Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 101. South America Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 102. South America Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 103. South America Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 104. South America Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 105. South America Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Middle East & Africa Biciruizumab Sales Quantity by Type (2021-2026) & (Units)
Table 107. Middle East & Africa Biciruizumab Sales Quantity by Type (2027-2032) & (Units)
Table 108. Middle East & Africa Biciruizumab Sales Quantity by Application (2021-2026) & (Units)
Table 109. Middle East & Africa Biciruizumab Sales Quantity by Application (2027-2032) & (Units)
Table 110. Middle East & Africa Biciruizumab Sales Quantity by Country (2021-2026) & (Units)
Table 111. Middle East & Africa Biciruizumab Sales Quantity by Country (2027-2032) & (Units)
Table 112. Middle East & Africa Biciruizumab Consumption Value by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Biciruizumab Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Biciruizumab Raw Material
Table 115. Key Manufacturers of Biciruizumab Raw Materials
Table 116. Biciruizumab Typical Distributors
Table 117. Biciruizumab Typical Customers
LIST OF FIGURES
Figure 1. Biciruizumab Picture
Figure 2. Global Biciruizumab Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biciruizumab Revenue Market Share by Type in 2025
Figure 4. 100 mg/4 mL Examples
Figure 5. 320 mg/2 mL Examples
Figure 6. Global Biciruizumab Revenue by Specification, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Biciruizumab Revenue Market Share by Specification in 2025
Figure 8. Bimekizumab In Combination With Methotrexate Examples
Figure 9. Bimekizumab Combined With Topical Corticosteroids Examples
Figure 10. Global Biciruizumab Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Biciruizumab Revenue Market Share by Sales Channels in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Global Biciruizumab Revenue by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Biciruizumab Revenue Market Share by Dosage Form in 2025
Figure 17. Intravenous Injection Examples
Figure 18. Subcutaneous Injection Examples
Figure 19. Global Biciruizumab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Biciruizumab Revenue Market Share by Application in 2025
Figure 21. Psoriasis Examples
Figure 22. Ankylosing Spondylitis Examples
Figure 23. Hidradenitis Suppurativa Examples
Figure 24. Others Examples
Figure 25. Global Biciruizumab Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Biciruizumab Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Biciruizumab Sales Quantity (2021-2032) & (Units)
Figure 28. Global Biciruizumab Price (2021-2032) & (US$/Unit)
Figure 29. Global Biciruizumab Sales Quantity Market Share by Manufacturer in 2025
Figure 30. Global Biciruizumab Revenue Market Share by Manufacturer in 2025
Figure 31. Producer Shipments of Biciruizumab by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 32. Top 3 Biciruizumab Manufacturer (Revenue) Market Share in 2025
Figure 33. Top 6 Biciruizumab Manufacturer (Revenue) Market Share in 2025
Figure 34. Global Biciruizumab Sales Quantity Market Share by Region (2021-2032)
Figure 35. Global Biciruizumab Consumption Value Market Share by Region (2021-2032)
Figure 36. North America Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 38. Asia-Pacific Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 39. South America Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 40. Middle East & Africa Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 41. Global Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 42. Global Biciruizumab Consumption Value Market Share by Type (2021-2032)
Figure 43. Global Biciruizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 44. Global Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 45. Global Biciruizumab Revenue Market Share by Application (2021-2032)
Figure 46. Global Biciruizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. North America Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 48. North America Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 49. North America Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 50. North America Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 51. United States Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 55. Europe Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 56. Europe Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 57. Europe Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 59. France Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Biciruizumab Sales Quantity Market Share by Region (2021-2032)
Figure 66. Asia-Pacific Biciruizumab Consumption Value Market Share by Region (2021-2032)
Figure 67. China Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 68. Japan Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 69. South Korea Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 70. India Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 71. Southeast Asia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 72. Australia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 73. South America Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 74. South America Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 75. South America Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 76. South America Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 77. Brazil Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 78. Argentina Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 79. Middle East & Africa Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 80. Middle East & Africa Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 81. Middle East & Africa Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 82. Middle East & Africa Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 84. Egypt Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 85. Saudi Arabia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 86. South Africa Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 87. Biciruizumab Market Drivers
Figure 88. Biciruizumab Market Restraints
Figure 89. Biciruizumab Market Trends
Figure 90. Porters Five Forces Analysis
Figure 91. Manufacturing Cost Structure Analysis of Biciruizumab in 2025
Figure 92. Manufacturing Process Analysis of Biciruizumab
Figure 93. Biciruizumab Industrial Chain
Figure 94. Sales Channel: Direct to End-User vs Distributors
Figure 95. Direct Channel Pros & Cons
Figure 96. Indirect Channel Pros & Cons
Figure 97. Methodology
Figure 98. Research Process and Data Source
Figure 1. Biciruizumab Picture
Figure 2. Global Biciruizumab Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biciruizumab Revenue Market Share by Type in 2025
Figure 4. 100 mg/4 mL Examples
Figure 5. 320 mg/2 mL Examples
Figure 6. Global Biciruizumab Revenue by Specification, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Biciruizumab Revenue Market Share by Specification in 2025
Figure 8. Bimekizumab In Combination With Methotrexate Examples
Figure 9. Bimekizumab Combined With Topical Corticosteroids Examples
Figure 10. Global Biciruizumab Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Biciruizumab Revenue Market Share by Sales Channels in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Global Biciruizumab Revenue by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Biciruizumab Revenue Market Share by Dosage Form in 2025
Figure 17. Intravenous Injection Examples
Figure 18. Subcutaneous Injection Examples
Figure 19. Global Biciruizumab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Biciruizumab Revenue Market Share by Application in 2025
Figure 21. Psoriasis Examples
Figure 22. Ankylosing Spondylitis Examples
Figure 23. Hidradenitis Suppurativa Examples
Figure 24. Others Examples
Figure 25. Global Biciruizumab Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Biciruizumab Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Biciruizumab Sales Quantity (2021-2032) & (Units)
Figure 28. Global Biciruizumab Price (2021-2032) & (US$/Unit)
Figure 29. Global Biciruizumab Sales Quantity Market Share by Manufacturer in 2025
Figure 30. Global Biciruizumab Revenue Market Share by Manufacturer in 2025
Figure 31. Producer Shipments of Biciruizumab by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 32. Top 3 Biciruizumab Manufacturer (Revenue) Market Share in 2025
Figure 33. Top 6 Biciruizumab Manufacturer (Revenue) Market Share in 2025
Figure 34. Global Biciruizumab Sales Quantity Market Share by Region (2021-2032)
Figure 35. Global Biciruizumab Consumption Value Market Share by Region (2021-2032)
Figure 36. North America Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 38. Asia-Pacific Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 39. South America Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 40. Middle East & Africa Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 41. Global Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 42. Global Biciruizumab Consumption Value Market Share by Type (2021-2032)
Figure 43. Global Biciruizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 44. Global Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 45. Global Biciruizumab Revenue Market Share by Application (2021-2032)
Figure 46. Global Biciruizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. North America Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 48. North America Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 49. North America Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 50. North America Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 51. United States Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 55. Europe Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 56. Europe Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 57. Europe Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 59. France Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Biciruizumab Sales Quantity Market Share by Region (2021-2032)
Figure 66. Asia-Pacific Biciruizumab Consumption Value Market Share by Region (2021-2032)
Figure 67. China Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 68. Japan Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 69. South Korea Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 70. India Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 71. Southeast Asia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 72. Australia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 73. South America Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 74. South America Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 75. South America Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 76. South America Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 77. Brazil Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 78. Argentina Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 79. Middle East & Africa Biciruizumab Sales Quantity Market Share by Type (2021-2032)
Figure 80. Middle East & Africa Biciruizumab Sales Quantity Market Share by Application (2021-2032)
Figure 81. Middle East & Africa Biciruizumab Sales Quantity Market Share by Country (2021-2032)
Figure 82. Middle East & Africa Biciruizumab Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 84. Egypt Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 85. Saudi Arabia Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 86. South Africa Biciruizumab Consumption Value (2021-2032) & (USD Million)
Figure 87. Biciruizumab Market Drivers
Figure 88. Biciruizumab Market Restraints
Figure 89. Biciruizumab Market Trends
Figure 90. Porters Five Forces Analysis
Figure 91. Manufacturing Cost Structure Analysis of Biciruizumab in 2025
Figure 92. Manufacturing Process Analysis of Biciruizumab
Figure 93. Biciruizumab Industrial Chain
Figure 94. Sales Channel: Direct to End-User vs Distributors
Figure 95. Direct Channel Pros & Cons
Figure 96. Indirect Channel Pros & Cons
Figure 97. Methodology
Figure 98. Research Process and Data Source
